Net loss of Indoco Remedies reported to Rs 40.39 crore in the quarter ended March 2025 as against net profit of Rs 22.70 crore during the previous quarter ended March 2024. Sales declined 12.57% to Rs 383.89 crore in the quarter ended March 2025 as against Rs 439.08 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 73.74 crore in the year ended March 2025 as against net profit of Rs 98.47 crore during the previous year ended March 2024. Sales declined 8.22% to Rs 1641.29 crore in the year ended March 2025 as against Rs 1788.22 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 383.89 | 439.08 | -13 | 1641.29 | 1788.22 | -8 |
| OPM % | -0.20 | 11.13 | - | 6.05 | 13.66 | - |
| PBDT | -16.74 | 39.48 | PL | 38.48 | 216.14 | -82 |
| PBT | -45.52 | 13.25 | PL | -75.36 | 124.27 | PL |
| NP | -40.39 | 22.70 | PL | -73.74 | 98.47 | PL |